EMA finalises first set of guidelines on good pharmacovigilance practice ahead of 2 July deadline
This article was originally published in SRA
Executive Summary
The European Medicines Agency has finalised its first ever set of guidance documents on good pharmacovigilance practices (GVP) to help drug companies comply with the provisions of the new EU pharmacovigilance legislation that will apply from 2 July1.